Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Levite

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Nature Immunology|May 29, 2002
Autoimmune epilepsyMia Levite
Neural Regeneration Research|December 1, 2022
Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptidesMia Levite
Journal of Neural Transmission (Vienna, Austria : 1996)|August 2, 2014
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapyMia Levite
Journal of Neural Transmission (Vienna, Austria : 1996)|February 26, 2017
Glutamate, T cells and multiple sclerosisMia Levite
Current Opinion in Pharmacology|July 23, 2008
Towards unveiling the mystery: from stressed brain/mind to outburst of diseaseMia Levite
Current Opinion in Pharmacology|June 27, 2008
Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptorsMia Levite
Frontiers in Immunology|April 19, 2021
T Cells Plead for Rejuvenation and Amplification; With the Brain's Neurotransmitters and Neuropeptides We Can Make It HappenMia Levite
Expert Review of Neurotherapeutics|July 2, 2008
Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitisMia Levite, Yonatan Ganor
Journal of Neural Transmission (Vienna, Austria : 1996)|March 4, 2014
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cellsYonatan Ganor, Mia Levite
Frontiers in Immunology|January 31, 2022
Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and InsightsMia Levite, Hadassa Goldberg
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Nature Immunology|May 29, 2002
Autoimmune epilepsyMia Levite
Neural Regeneration Research|December 1, 2022
Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptidesMia Levite
Journal of Neural Transmission (Vienna, Austria : 1996)|August 2, 2014
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapyMia Levite
Journal of Neural Transmission (Vienna, Austria : 1996)|February 26, 2017
Glutamate, T cells and multiple sclerosisMia Levite
Current Opinion in Pharmacology|July 23, 2008
Towards unveiling the mystery: from stressed brain/mind to outburst of diseaseMia Levite
Current Opinion in Pharmacology|June 27, 2008
Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptorsMia Levite
Frontiers in Immunology|April 19, 2021
T Cells Plead for Rejuvenation and Amplification; With the Brain's Neurotransmitters and Neuropeptides We Can Make It HappenMia Levite
Expert Review of Neurotherapeutics|July 2, 2008
Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitisMia Levite, Yonatan Ganor
Journal of Neural Transmission (Vienna, Austria : 1996)|March 4, 2014
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cellsYonatan Ganor, Mia Levite
Frontiers in Immunology|January 31, 2022
Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and InsightsMia Levite, Hadassa Goldberg
Pageof 4